Skip to main content
OpenTrials
Completed

NCT Number: NCT05978427

Efficacy and Safety of Superior Trunk Block Versus Interscalene Block for Post-operative Analgesia in Shoulder Surgeries

Efficacy and safety of superior trunk block versus interscalene block for post-operative analgesia in shoulder surgeries

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ainshams University

Cairo, Egypt

About this study

The interscalene brachial plexus block is the gold standard analgesic technique for surgery involving the shoulder and upper arm. However, due to its complications as hemidiaphragmatic paralysis, the superior trunk block was developed in an attempt to reduce major complications.The utility of the superior trunk block has yet to be studied in shoulder surgeries.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients American Society of Anaesthesiologists physical status (ASA) is I to II.
  • Both genders.
  • Aged group from 21 to 50 years old.
  • Patients electively scheduled for shoulder surgery under general anesthesia with normal coagulation profile.

Exclusion criteria

  • Refusal of the procedure or participation in the study.
  • Any history or evidence of coagulopathy.
  • Evidence of infection at injection site.
  • Allergy to study drugs.
  • Patients with pulmonary severe respiratory disease.
  • Herniated cervical disc or cervical myelopathy.
  • Pre-existing neuropathy of the operative limb

Treatment and study plan

interscalene block

Procedure

will receive a 20 ml mixture of local anesthetic solution prepared as 10 ml of bupivacaine 0.5% diluted with 10 ml normal saline 0.9% will be injected in interscalene block.

Superior trunk block

Procedure

will receive a 20 ml mixture of local anesthetic solution prepared as 10 ml of bupivacaine 0.5% diluted with 10 ml normal saline 0.9% will be injected in superior trunk block.

Primary outcomes

  1. diaphragmatic paralysis postoperative

    Time frame: within 24 hours after surgery

    o The incidence of diaphragmatic paralysis postoperative assessed by Diaphragmatic excursion distance by Ultrasound

Secondary outcomes

  1. analgesic efficacy

    Time frame: within 24 hours after surgery

    o Analgesic efficacy of the nerve block in both groups by assessing postoperative pain vas score

  2. rescue analgesia

    Time frame: within 24 hours after surgery

    The total amount of rescue analgesia used

  3. Post operative nausea and vomiting

    Time frame: within 24 hours after surgery

    incidence of post operative complications as nausea an vomiting

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Aug 7, 2023
Registry last updated
Jun 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.